相关实验视频

Updated: Jul 5, 2025

Videomorphometric Analysis of Hypoxic Pulmonary Vasoconstriction of Intra-pulmonary Arteries Using Murine Precision Cut Lung Slices

Videomorphometric Analysis of Hypoxic Pulmonary Vasoconstriction of Intra-pulmonary Arteries Using Murine Precision Cut Lung Slices

Published on: January 14, 2014

细胞通过HIF2α信号传递促进肺血管重塑

Hyunbum Kim¹, Yu Liu², Jiwon Kim¹

¹Division of Pulmonary Medicine, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.

|January 19, 2024

概括

细胞在血管改造中经常被忽视,在肺动脉高血压 (PAH) 中起着关键作用. 皮细胞中低氧诱导因子2α (HIF2α) 的增加推动了疾病的进展,这表明HIF2α是PAH的潜在治疗标.

科学领域:

心血管生物学心血管生物学
细胞生物学细胞生物学
肺高血压研究肺高血压研究

背景情况:

血管改造是心血管疾病的核心,如肺动脉高血压 (PAH).
毛细血管中的关键细胞细胞在血管重塑和PAH的研究中基本上被忽视了.
现有的研究主要集中在血管重塑中的内皮细胞和光滑肌细胞.

研究的目的:

调查皮质细胞在肺血管改造和PAH中的作用.
为了确定分子调节者参与PAH期间的细胞体转化.
探索缺氧诱导因子2α (HIF2α) 作为PAH的潜在治疗点.

主要方法:

对PAH患者的肺组织进行分析,以评估HIF2α表达.
利用单细胞RNA测序 (scRNAseq) 来分析细胞变化.
采用低氧诱导的肺高血压 (PH) 鼠标模型,具有周细胞选择性HIF2α过度表达.
进行了时间细胞系的追踪,以追踪细胞迁移和分化.

主要成果:

低氧诱导因子2α (HIF2α) 的表达在PAH患者的肺组织中升高.
皮细胞中HIF2α的过度表达导致收缩性增加和内皮细胞-皮细胞相互作用受损.
HIF2α驱动皮质细胞转化为类似光滑肌肉细胞 (SMC).
细胞选择性HIF2α过度表达加剧了小鼠的肺高血压和右心室缩.
表达HIF2α的NG2+细胞周细胞 (细胞周细胞选择性) 从毛细血管迁移到动脉小细胞,并表达阿尔法平滑肌肉动蛋白 (SMA).

结论:

在肺血管改造中,HIF2α 是围细胞转化的关键分子调节器.
细胞在PAH的发病过程中发挥着重要的,以前被低估的作用.
向皮细胞中的HIF2α信号提供了一个有前途的治疗策略来治疗PAH.

关键词:

如果HIF2α 危险细胞 (Pericyte) 是一种危险细胞.肺高血压是什么意思肺高血压血管改造血管改造血管改造

更多相关视频

A High Output Method to Isolate Cerebral Pericytes from Mouse

A High Output Method to Isolate Cerebral Pericytes from Mouse

Published on: January 14, 2020

Angiogenesis in the Ischemic Rat Lung

Angiogenesis in the Ischemic Rat Lung

Published on: February 8, 2013

相关概念视频

Regulation of Angiogenesis and Blood Supply

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...

Mechanism of Angiogenesis

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...

Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists

Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists

Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...